2 documents found, page 1 of 1
The Second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany
Berntorp, E; Dargaud, Y; Hart, D; Lobet, S; Mancuso, ME; d'Oiron, R; Perry, D; Pollard, D; van den Berg, M; Blatný, J; Chambost, H; Doria, AS; Holme, PAThe first Team Haemophilia Education (THE) Meeting was held on 7-8 May 2015 in Amsterdam, The Netherlands. It aimed to promote the optimal care of patients with haemophilia through education of the multidisciplinary treatment team. This was achieved by reviewing the latest developments in haemophilia management, considering how these can be implemented in the clinic to improve patient care and providing a platf...
Non-Genetic Risk Factors and the Development of Inhibitors in Haemophilia: a Co...
Astermark, J; Altisent, C; Batorova, A; Diniz, MJ; Gringeri, A; Holme, PA; Karafoulidou, A; Lopez-Fernández, MF; Reipert, BM; Rocino, A; Schiavoni, MThe development of inhibitors to the infused factor in patients with haemophilia is a serious clinical problem. Recent evidence suggests that alongside the strong genetic contribution to inhibitor formation, there are a number of non-genetic factors--perceived by the immune system as danger signals--which promote formation of inhibitors. This study provides a comprehensive review of clinical studies relating to...